GAMMA Investing’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8K Sell
857
-371
-30% -$3.99K ﹤0.01% 3084
2026
Q1
$10.4K Buy
1,228
+1,212
+7,575% +$13.3K ﹤0.01% 3055
2025
Q4
$181 Sell
16
-131
-89% -$1.62K ﹤0.01% 4003
2025
Q3
$2.21K Buy
147
+67
+84% +$975 ﹤0.01% 3427
2025
Q2
$1.13K Sell
80
-276
-78% -$4.92K ﹤0.01% 3515
2025
Q1
$8.56K Buy
356
+261
+275% +$9.2K ﹤0.01% 2827
2024
Q4
$3.55K Sell
95
-30
-24% -$1.4K ﹤0.01% 3046
2024
Q3
$6.25K Buy
125
+76
+155% +$2.96K ﹤0.01% 2664
2024
Q2
$1.7K Sell
49
-1
-2% -$40 ﹤0.01% 2929
2024
Q1
$2.73K Buy
50
+24
+92% +$1.19K ﹤0.01% 2645
2023
Q4
$1.16K Buy
+26
New +$809 ﹤0.01% 2753

Other funds holding BHVN

GAMMA Investing's BHVN Position: Q2 2026 in Review

GAMMA Investing reduced its Biohaven (BHVN) stake by 30% in Q2 2026, selling an estimated $3.99K and leaving 857 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3084.

GAMMA Investing first reported a position in BHVN in Q4 2023 and has held it in 11 quarters since. 25 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • GAMMA Investing held 857 shares of Biohaven worth $12.8K as of Q2 2026.
  • GAMMA Investing sold 371 Biohaven shares in Q2 2026, an estimated $3.99K.
  • Biohaven made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3084 holding.
  • GAMMA Investing first reported a position in Biohaven in Q4 2023 and has held it in 11 quarters since.
  • 25 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.